Allied Minds

Verified Timeline

Lore & Background

The company's history is defined by strategic partnerships that expanded its reach from private agreements to major public collaborations. In 2012, it entered an innovative arrangement with the United States Department of Defense to form incubation-stage companies for advanced wireless and internet networking technologies. This private-public partnership subsequently expanded to include the U.S. Army's Research Development, and Engineering Command, the Naval Surface Warfare Center (Crane Division), and The Aerospace Corp. A pivotal moment occurred in October 2013 when Allied Minds signed an agreement with The MITRE Corp. for cyber and mobile security sharing; this was later expanded in July 2016 to grant its federal division, Allied Minds Federal Innovations (AMFI), exclusive access to the portfolio. In August 2014, a joint venture named Allied-Bristol Life Sciences was announced with Bristol-Myers Squibb to form biotech companies based on university discoveries, receiving new funding in April 2016 for pre-clinical drug development. Later that year, in September 2016, the company partnered with General Electric Co.'s venture capital unit to invest in new companies across healthcare, transportation, energy, and big data sectors.

In Their Own Story

The trajectory of Allied Minds shifted dramatically from a publicly traded entity to a privately held one. After listing on the London Stock Exchange following its June 2014 IPO, the company faced market volatility that culminated in November 2022. A 64% fall in its share price over the preceding year forced the delisting of Allied Minds from the exchange, ending its public trading status and marking a transition back to private ownership. Throughout this period, the company maintained an aggressive expansion strategy, leveraging its network of 130 American universities and 30 federal government departments. The formation of specific subsidiaries and joint ventures, such as those with MITRE and GE Ventures, demonstrated a consistent operational model: identifying underutilized intellectual property within research networks and creating dedicated start-ups to bring these technologies to market.

Reader's Guide

For researchers and partners looking to engage with Allied Minds, the process centers on technology transfer agreements that facilitate the creation of new subsidiaries. The company reviews numerous IP assets per year, seeking opportunities where advanced technologies can be prepared for the market through incubation. Partners include major academic institutions like Harvard and New York University, as well as 34 U.S. federal research facilities. Specific pathways exist for different sectors; for instance, the partnership with MITRE focuses on cyber and mobile security, while the venture with Bristol-Myers Squibb targets biotech developments from university laboratories. The joint investment framework with GE Ventures allows for capital to flow into existing Allied Minds subsidiaries, in-house technologies GE wishes to spin out, or new startups sourced jointly. This model requires a commitment to forming new entities rather than simply licensing patents, ensuring that the commercialized IP operates as an independent subsidiary managed and funded by Allied Minds.

Did You Know?

• Allied Minds was established in 2004 specifically to exploit opportunities in intellectual property.
• The company formed an innovative arrangement with the U.S. Department of Defense in 2012 to incubate advanced wireless and internet networking technologies.
• In July 2016, Allied Minds Federal Innovations (AMFI) was granted exclusive access to The MITRE Corp.'s cyber and mobile security portfolio.
• Allied Minds delisted from the London Stock Exchange in November 2022 after its share price fell by 64% over the previous year.
• The company operates a relatively new IP commercialization model for the U.S. that involves forming, funding, and managing start-ups as subsidiaries.